A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
The authors identified a protective genetic allele associated with lower PU.1 ( SPI1 ) expression in myeloid cells by conducting a genome-wide scan of Alzheimer's disease (AD). PU.1 binds the promoters of AD-associated genes (e.g., CD33 , MS4A4A & MS4A6A , TYROBP ) and modulates their expre...
Saved in:
Published in | Nature neuroscience Vol. 20; no. 8; pp. 1052 - 1061 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.08.2017
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The authors identified a protective genetic allele associated with lower PU.1 (
SPI1
) expression in myeloid cells by conducting a genome-wide scan of Alzheimer's disease (AD). PU.1 binds the promoters of AD-associated genes (e.g.,
CD33
,
MS4A4A
&
MS4A6A
,
TYROBP
) and modulates their expression, suggesting it may reduce AD risk by regulating myeloid cell gene expression.
A genome-wide survival analysis of 14,406 Alzheimer's disease (AD) cases and 25,849 controls identified eight previously reported AD risk loci and 14 novel loci associated with age at onset. Linkage disequilibrium score regression of 220 cell types implicated the regulation of myeloid gene expression in AD risk. The minor allele of rs1057233 (G), within the previously reported
CELF1
AD risk locus, showed association with delayed AD onset and lower expression of
SPI1
in monocytes and macrophages.
SPI1
encodes PU.1, a transcription factor critical for myeloid cell development and function. AD heritability was enriched within the PU.1 cistrome, implicating a myeloid PU.1 target gene network in AD. Finally, experimentally altered PU.1 levels affected the expression of mouse orthologs of many AD risk genes and the phagocytic activity of mouse microglial cells. Our results suggest that lower
SPI1
expression reduces AD risk by regulating myeloid gene expression and cell function. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Data used in the preparation of this article were obtained from the International Genomics of Alzheimer’s Project (IGAP), the investigators from which did not participate in the work reported herein. IGAP authors and affiliations are documented in the 2013 landmark IGAP publication1 These authors contributed equally to this work Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf |
ISSN: | 1097-6256 1546-1726 |
DOI: | 10.1038/nn.4587 |